Literature DB >> 12503591

The role of HLA antigens in chronic hepatitis B virus infection.

M A Karan1, N Erten Tascioglu, A O Ozturk, S Palanduz, M Carin.   

Abstract

OBJECTIVE: To investigate the mechanism underlying the development of chronic hepatitis B virus infection (HBV) in Turkish population using HLA tissue typing.
METHODS: The study group I consisted of 20 patients with HBV-related chronic liver disease (cirrhosis, chronic active hepatitis or chronic persistent hepatitis). The study group II included 30 HBV chronic carriers. The control group consisted of 50 healthy subjects with negative serologic markers for HBV. HLA typing was performed by Terasaki's microlymphocytotoxicity method.
RESULTS: The frequencies of HLA-DR13 and DQ3 were significantly higher in the patients with HBV-related chronic liver disease compared to those of control group. The absence of HLA-A24 and CW1 was also significant in group I. The frequencies of HLA A2, B8, B13, CW3, DR13 were significantly higher in group II compared to the control group. There were increased frequencies of HLA- B8, B13, DR7, DR13, and DQ3 in both group I and group II.
CONCLUSION: HLA-A24 AND Cw1 were associated with low risk for HBV-related chronic liver disease and HLA- B13, B8, DR7, DR13 and DQ3 were associated with high risk for chronic HBV infection in the Turkish population (JPMA 52:253;2002).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12503591

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  8 in total

1.  Relationship between polymorphism of class II transactivator gene promoters and chronic hepatitis B.

Authors:  Ying-Ren Zhao; Ling Gong; Ying-Li He; Fang Liu; Chang Lu
Journal:  World J Gastroenterol       Date:  2005-02-14       Impact factor: 5.742

2.  HLA targeting efficiency correlates with human T-cell response magnitude and with mortality from influenza A infection.

Authors:  Tomer Hertz; Christine M Oshansky; Philippa L Roddam; John P DeVincenzo; Miguela A Caniza; Nebojsa Jojic; Simon Mallal; Elizabeth Phillips; Ian James; M Elizabeth Halloran; Paul G Thomas; Lawrence Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

Review 3.  A comparative review of HLA associations with hepatitis B and C viral infections across global populations.

Authors:  Rashmi Singh; Rashmi Kaul; Anil Kaul; Khalid Khan
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

4.  Association of human leukocyte antigen DQB1 and DRB1 alleles with chronic hepatitis B.

Authors:  Levent Doganay; Arta Fejzullahu; Seyma Katrinli; Feruze Yilmaz Enc; Oguzhan Ozturk; Yasar Colak; Celal Ulasoglu; Ilyas Tuncer; Gizem Dinler Doganay
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

5.  The influence of human leukocyte antigen and IL-10 gene polymorphisms on hepatitis B virus outcome.

Authors:  Amitis Ramezani; Mohammad Banifazl; Setareh Mamishi; Masoomeh Sofian; Ali Eslamifar; Arezoo Aghakhani
Journal:  Hepat Mon       Date:  2012-05-30       Impact factor: 0.660

Review 6.  Hepatitis B virus in Pakistan: a systematic review of prevalence, risk factors, awareness status and genotypes.

Authors:  Muhammad Ali; Muhammad Idrees; Liaqat Ali; Abrar Hussain; Irshad Ur Rehman; Sana Saleem; Samia Afzal; Sadia Butt
Journal:  Virol J       Date:  2011-03-06       Impact factor: 4.099

7.  Association of human leukocyte antigen class I polymorphism with spontaneous clearance of hepatitis B surface antigen in Qidong Han population.

Authors:  Fengqin Miao; Hang Sun; Ning Pan; Jinhuan Xu; Jie Qiu; Yuqing Shen; Wei Xie; Jianqiong Zhang
Journal:  Clin Dev Immunol       Date:  2013-11-13

8.  In Silico Prediction of Human Leukocytes Antigen (HLA) Class II Binding Hepatitis B Virus (HBV) Peptides in Botswana.

Authors:  Wonderful Tatenda Choga; Motswedi Anderson; Edward Zumbika; Bonolo B Phinius; Tshepiso Mbangiwa; Lynnette N Bhebhe; Kabo Baruti; Peter Opiyo Kimathi; Kaelo K Seatla; Rosemary M Musonda; Trevor Graham Bell; Sikhulile Moyo; Jason T Blackard; Simani Gaseitsiwe
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.818

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.